BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 33228173)

  • 1. Risk of Developing Pancreatic Cancer in Patients with Chronic Pancreatitis.
    Vujasinovic M; Dugic A; Maisonneuve P; Aljic A; Berggren R; Panic N; Valente R; Pozzi Mucelli R; Waldthaler A; Ghorbani P; Kordes M; Hagström H; Löhr JM
    J Clin Med; 2020 Nov; 9(11):. PubMed ID: 33228173
    [No Abstract]   [Full Text] [Related]  

  • 2. Incidence and Risk of Pancreatic Cancer in Patients with a New Diagnosis of Chronic Pancreatitis.
    Munigala S; Subramaniam DS; Subramaniam DP; Burroughs TE; Conwell DL; Sheth SG
    Dig Dis Sci; 2022 Feb; 67(2):708-715. PubMed ID: 33630214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zinc deficiency in patients with chronic pancreatitis.
    Vujasinovic M; Hedström A; Maisonneuve P; Valente R; von Horn H; Löhr JM; Haas SL
    World J Gastroenterol; 2019 Feb; 25(5):600-607. PubMed ID: 30774274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic exocrine insufficiency is a risk factor for kidney stones in patients with chronic pancreatitis.
    Vujasinovic M; Dugic A; Thiel T; Kjellman A; Yang C; Löhr JM
    Pancreatology; 2023 Apr; 23(3):294-298. PubMed ID: 36990843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor 1 and insulin-like growth factor binding protein 2 serum levels as potential biomarkers in differential diagnosis between chronic pancreatitis and pancreatic adenocarcinoma in reference to pancreatic diabetes.
    Włodarczyk B; Borkowska A; Włodarczyk P; Małecka-Panas E; Gąsiorowska A
    Prz Gastroenterol; 2021; 16(1):36-42. PubMed ID: 33986886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Reduced Pancreatic Polypeptide Response is Associated With New-onset Pancreatogenic Diabetes Versus Type 2 Diabetes.
    Hart PA; Kudva YC; Yadav D; Andersen DK; Li Y; Toledo FGS; Wang F; Bellin MD; Bradley D; Brand RE; Cusi K; Fisher W; Mather K; Park WG; Saeed Z; Considine RV; Graham SC; Rinaudo JA; Serrano J; Goodarzi MO
    J Clin Endocrinol Metab; 2023 Apr; 108(5):e120-e128. PubMed ID: 36404274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic Pancreatitis Is a Risk Factor for Pancreatic Cancer, and Incidence Increases With Duration of Disease: A Systematic Review and Meta-analysis.
    Gandhi S; de la Fuente J; Murad MH; Majumder S
    Clin Transl Gastroenterol; 2022 Mar; 13(3):e00463. PubMed ID: 35142721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute Pancreatitis Recurrences Augment Long-Term Pancreatic Cancer Risk.
    Munigala S; Almaskeen S; Subramaniam DS; Bandi S; Bowe B; Xian H; Sheth SG; Burroughs TE; Agarwal B
    Am J Gastroenterol; 2023 Apr; 118(4):727-737. PubMed ID: 36473072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct pathophysiological cytokine profiles for discrimination between autoimmune pancreatitis, chronic pancreatitis, and pancreatic ductal adenocarcinoma.
    Ghassem-Zadeh S; Gaida MM; Szanyi S; Acha-Orbea H; Frossard JL; Hinz U; Hackert T; Strobel O; Felix K
    J Transl Med; 2017 Jun; 15(1):126. PubMed ID: 28578701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CT- and MRI-Based Assessment of Body Composition and Pancreatic Fibrosis Reveals High Incidence of Clinically Significant Metabolic Changes That Affect the Quality of Life and Treatment Outcomes of Patients with Chronic Pancreatitis and Pancreatic Cancer.
    Bieliuniene E; Brøndum Frøkjær J; Pockevicius A; Kemesiene J; Lukosevičius S; Basevicius A; Atstupenaite V; Barauskas G; Ignatavicius P; Gulbinas A; Dambrauskas Z
    Medicina (Kaunas); 2019 Sep; 55(10):. PubMed ID: 31569661
    [No Abstract]   [Full Text] [Related]  

  • 11. Unique circulating immune signatures for recurrent acute pancreatitis, chronic pancreatitis and pancreatic cancer: A pilot study of these conditions with and without diabetes.
    Park WG; Li L; Appana S; Wei W; Stello K; Andersen DK; Hughes SJ; Whitcomb DC; Brand RE; Yadav D; Habtezion A;
    Pancreatology; 2020 Jan; 20(1):51-59. PubMed ID: 31791885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of different serum fibrosis markers in diagnosing patients with chronic pancreatitis and pancreatic adenocarcinoma.
    Kozak A; Talar-Wojnarowska R; Kaczka A; Borkowska A; Czupryniak L; Małecka-Panas E; Gąsiorowska A
    World J Gastrointest Oncol; 2016 Aug; 8(8):635-41. PubMed ID: 27574557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific increase in serum core-fucosylated haptoglobin in patients with chronic pancreatitis.
    Ueda M; Kamada Y; Takamatsu S; Shimomura M; Maekawa T; Sobajima T; Fujii H; Nakayama K; Nishino K; Yamada M; Kobayashi Y; Kumada T; Ito T; Eguchi H; Nagano H; Miyoshi E
    Pancreatology; 2016; 16(2):238-43. PubMed ID: 26897254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum miR-210-3p can be used to differentiate between patients with pancreatic ductal adenocarcinoma and chronic pancreatitis.
    Guz M; Jeleniewicz W; Cybulski M; Kozicka J; Kurzepa J; Mądro A
    Biomed Rep; 2021 Jan; 14(1):10. PubMed ID: 33235725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of insulin-like growth factor (IGF-1) and retinol binding protein (RBP-4) levels in patients with newly diagnosed pancreatic adenocarcinoma (PDAC).
    Wlodarczyk B; Gasiorowska A; Borkowska A; Malecka-Panas E
    Pancreatology; 2017; 17(4):623-628. PubMed ID: 28499807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilising Pancreatic Exocrine Insufficiency in the Detection of Resectable Pancreatic Ductal Adenocarcinoma.
    McDonnell D; Afolabi PR; Wilding S; Griffiths GO; Swann JR; Byrne CD; Hamady ZZ
    Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic pancreatitis and resectable synchronous pancreatic carcinoma: A survival analysis.
    Birgin E; Hablawetz P; Téoule P; Rückert F; Wilhelm TJ
    Pancreatology; 2018 Jun; 18(4):394-398. PubMed ID: 29716797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatitis-diabetes-pancreatic cancer: summary of an NIDDK-NCI workshop.
    Andersen DK; Andren-Sandberg Å; Duell EJ; Goggins M; Korc M; Petersen GM; Smith JP; Whitcomb DC
    Pancreas; 2013 Nov; 42(8):1227-37. PubMed ID: 24152948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignancy in chronic pancreatitis: analysis of diagnostic procedures and proposal of a clinical algorithm.
    Rückert F; Brussig T; Kuhn M; Kersting S; Bunk A; Hunger M; Saeger HD; Niedergethmann M; Post S; Grützmann R
    Pancreatology; 2013; 13(3):243-9. PubMed ID: 23719595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Scandinavian baltic pancreatic club (SBPC) database: design, rationale and characterisation of the study cohort.
    Olesen SS; Poulsen JL; Drewes AM; Frøkjær JB; Laukkarinen J; Parhiala M; Rix I; Novovic S; Lindkvist B; Bexander L; Dimcevski G; Engjom T; Erchinger F; Haldorsen IS; Pukitis A; Ozola-Zālīte I; Haas S; Vujasinovic M; Löhr JM; Gulbinas A; Jensen NM; Jørgensen MT; Nøjgaard C;
    Scand J Gastroenterol; 2017 Aug; 52(8):909-915. PubMed ID: 28471312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.